Hyperion DeFi, Inc. (TRADEGATE:B0U) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Julia A. Haller Other companies: Outlook Therapeutics, Inc. (Director · Since at least Aug 11, 2022); Bristol-Myers Squibb Company (Ophthalmologist-in-Chief, Wills Eye Hospital · Since at least Nov 20, 2019); Celgene Corporation (Director · Oct 15, 2015 – Nov 20, 2019 · Past) | Director · Mar 31, 2021 – Jun 16, 2022 · Past |
| Ellen R. Strahlman Other companies: Altria Group, Inc. (Director · Since at least Nov 2, 2020); Becton, Dickinson and Company (Senior Vice President · Apr 22, 2013 – Nov 25, 2017 · Past) | Independent Board Member · Since at least Jul 1, 2022 |
| Ernest Mario Other companies: Kindred Biosciences Inc (Director · Jan 20, 2021 – Jan 20, 2021 · Past); Soleno Therapeutics, Inc. (Director · Oct 30, 2020 – Jun 6, 2024 · Past) | Director · Jan 15, 2021 – Nov 17, 2021 · Past |
| John P. Gandolfo Other companies: electroCore, Inc. (Audit Committee Member, Compensation Committee Member · Since at least Jun 13, 2024); Oragenics Inc. (Director · Since at least Oct 4, 2023) | Chief Financial Officer · Feb 12, 2024 – Feb 12, 2024 · Past |
| Kenneth B Lee Jr Other companies: BioCryst Pharmaceuticals, Inc. (Director · May 23, 2016 – Jun 13, 2023 · Past); Aralez Pharmaceuticals Inc (Director · May 13, 2016 – May 11, 2017 · Past) | Director · Mar 26, 2018 – Jun 16, 2022 · Past |
| Andrew D Jones Other companies: Stablecoin Development Corporation (CFO · May 4, 2020 – Feb 15, 2023 · Past) | Chief Financial Officer · Aug 30, 2024 – Aug 30, 2024 · Past |
| Charles E Mather IV Other companies: Tonix Pharmaceuticals Holding Corp. (Director · Apr 26, 2013 – Jun 12, 2018 · Past) | Director · Mar 26, 2018 – Apr 21, 2025 · Past |
| Bren Kern | Chief Operating Officer · Jan 1, 2023 – Apr 21, 2025 · Past |
| David Knox | Chief Financial Officer · Since at least Sep 29, 2025 |
| Happy Walters | Independent Board Member · Since at least Sep 8, 2025 |
| Hyunsu Jung | Chief Executive Officer · Since at least Jun 17, 2025 |
| Jennifer G Clasby | VP, Regulatory and Clinical · Jan 24, 2018 – Jun 17, 2021 · Past |
| Luke Clauson | VP Research & Development · Jan 24, 2018 – Jun 16, 2021 · Past |
| Michael Geltzeiler | Director · Since at least Nov 14, 2023 |
| Michael M Rowe | Chief Executive Officer, Director · Since at least Aug 1, 2022 |
| Rachel Jacobson | Independent Board Member · Since at least Feb 4, 2022 |
| Ram Palanki | Director · Jul 1, 2022 – Apr 21, 2025 · Past |
| Robert Rubenstein | General Counsel and Secretary · Since at least Jan 5, 2026 |
| Tsontcho Ianchulev | Director · Jul 11, 2019 – Apr 21, 2025 · Past |